SGLT2 Inhibitors Reduce Uric Acid-Related Adverse Events in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Author:
Affiliation:
1. Department of Pharmacy, Yeungnam University, 280 Daehak-Ro, Gyeongsan, Gyeongbuk 38541, Republic of Korea
2. Hospital pharmacy department, Yeungnam University, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Republic of Korea
Publisher
The Korean Society of Health-System Pharmacists
Subject
General Medicine
Link
https://pdf.medrang.co.kr/JKSHP/2023/040/JKSHP040-04-04.pdf
Reference31 articles.
1. Diabetes Fact Sheet in Korea 2022. Available from: https://www.diabetes.or.kr/bbs/?code=fact_sheet&mode=view&-number=2499&page=1&code=fact_sheet.
2. Sodium–Glucose Cotransporter–2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes
3. SGLT-2 Inhibitors: Ideal Remedy for Cardioprotection in Diabetes Mellitus
4. Park SY, Ryu DH, Kwon JE, et al. Comparisons of Efficacy Between Sodium-Glucose Cotransporter 2 Inhibitors and Dipeptidyl Peptidase 4 Inhibitors Add-on to Metformin Therapy in Type 2 Diabetes Mellitus Patient. J Kor Soc Health-syst Pharm. 2020;37(3):341-52.
5. The Side Effects of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3